AngioDynamics (ANGO) Tops Q1 EPS by 4c, Revenues Miss; Offers FY20 EPS Guidance Below Consensus, FY20 Mid-Point Revenue View Above Consensus

October 3, 2019 6:05 AM

AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found